The Discounted Cash Flow (DCF) valuation of DaShenLin Pharmaceutical Group Co Ltd (603233.SS) is 9.83 CNY. With the latest stock price at 17.78 CNY, the upside of DaShenLin Pharmaceutical Group Co Ltd based on DCF is -44.7%.
Based on the latest price of 17.78 CNY and our DCF valuation, DaShenLin Pharmaceutical Group Co Ltd (603233.SS) is a sell. selling 603233.SS stocks now will result in a potential gain of 44.7%.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 8.7% | 7.9% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 4.88 - 21.46 | 9.83 |
| Upside | -72.6% - 20.7% | -44.7% |